Episode Details

Back to Episodes
Could Eye Blood-Flow Scans Predict Glaucoma Progression Better Than Regular OCT? New 4-Year Results

Could Eye Blood-Flow Scans Predict Glaucoma Progression Better Than Regular OCT? New 4-Year Results

Published 2 weeks ago
Description

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/could-eye-blood-flow-scans-predict-glaucoma-progression-better-than-regular-oct-new-4-year-results

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

Could Eye Blood-Flow Scans Predict Glaucoma Progression Better Than Regular OCT? New 4-Year Results Short answer: Optical coherence tomography angiography (OCTA) may reveal glaucoma-related change when conventional retinal thickness measurements are no longer changing clearly—especially in some eyes with advanced glaucoma. But the new study does not prove that OCTA is superior to structural optical coherence tomography (OCT). It found an association between faster vessel-density loss and visual-field progression; it did not make a formal comparison of how well the two tests predict progression, and important methodological details are not available in the abstract. A key wording point: OCTA is not a direct blood-flow meter. It detects a signal from moving blood cells and maps vessels that are flowing fast enough to be detected. A falling vessel-density reading may reflect reduced flow signal, capillary loss, image quality, or a combination of these—not necessarily vessels physically disappearing. American Academy of Ophthalmology OCTA assessment What the October 28, 2026 study found The study, “Longitudinal OCT Angiography Versus Structural OCT for Predicting Visual Field Progression in Glaucoma,” was published in the Journal of Glaucoma on October 28, 2026. It followed 333 eyes with open-angle glaucoma, including 110 eyes with normal-tension glaucoma, for an average of 4.1 years. The reported results support OCTA as a potentially useful additional monitoring signal—but do not establish that it should replace OCT or visual-field testing. Journal of Glaucoma article record What can—and cannot—be reconstructed The study’s accessible abstract reports that it was a prospective study. The glaucoma eyes were followed quarterly; 60 age-matched healthy control eyes were examined at the start and again after six months. The researchers tracked: Peripapillary capillary vessel density: the capillary signal around the optic nerve. Macular vessel density: the capillary signal in the central retina, including the parafoveal area. Peripapillary retinal nerve fiber layer thickness: a structural OCT measurement around the optic nerve. Macular ganglion cell–inner plexiform layer thickness: a structural OCT measurement of retinal cells important to vision. Visual-field progression: worsening in the patient’s measured field of vision. The researchers compared change rates with linear mixed-effects models and used multivariable Cox models with cumulatively updated change rates as time-dependent predictors. Visual-field progression was described as being determined with combined event-based and trend-based criteria. Journal of Glaucoma article record There is an important limit to what can be verified: the accessible abstract does not provide the scan device, exact visual-field criteria, glaucoma-stage definitions, full list of model adjustments, or all numerical results. It also does not give confidence intervals for the structural-OCT hazard ratios or the rates of change in the healthy controls. I could not verify those details from a full Methods section or supplement for this review. They should not be guessed. The reported numerical results For the full table, please open this article on visualfieldtest.com. The macular vessel-density loss rates differed by 0.72 percentage po

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us